Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis
- PMID: 956814
- DOI: 10.1007/BF01249445
Time course of nigrostriatal degeneration in parkinson's disease. A detailed study of influential factors in human brain amine analysis
Abstract
It could be shown that the post mortem analysis of biogenic amines, precursors and metabolites in the human brain are influenced by various parameters. 1. The patient's medical history; long term observations of the course of the disease; age; sex. 2. Terminal illness; duration of terminal illness. 3. Previous treatment with drugs; last drugs. 4. Time interval between last drug treatment and death; time of day and date of last drug consumption. 5. Rapidity of death; time of death; duration of coma. 6. Changes occurring in tissues before death; patients' constitution during terminal illness. 7. Changes in concentration of the biogenic amines, precursors, and metabolites depending on the patient's age. 8. Time between death and necropsy. 9 Dissection of specimen. 10. Period of storage; temperature of storage. 11. Chronbiological rhythm of substances. 12. Methods of assayL 13. Homogeneity of all mentioned parameters in the control group and patient's group. For the first time it could be demonstrated that the time course of nigrostriatal degeneration, independent of the age of the parkinsonian at the beginning of the illness, is linear for the last stage and the denervation progressively increases as the duration of illness progresses.
Similar articles
-
Seasonal and circadian monoamine variations in human brains examined post mortem.Acta Psychiatr Scand Suppl. 1980;280:75-85. Acta Psychiatr Scand Suppl. 1980. PMID: 6157305 Review. No abstract available.
-
Regional distribution of monoamines and their metabolites in the human brain.J Neurochem. 1978 Apr;30(4):841-8. doi: 10.1111/j.1471-4159.1978.tb10792.x. J Neurochem. 1978. PMID: 650225 No abstract available.
-
[Age and changes in the levels of biogenic amines in the brains of rats].Fiziol Zh SSSR Im I M Sechenova. 1977 Mar;63(3):353-8. Fiziol Zh SSSR Im I M Sechenova. 1977. PMID: 863030 Russian.
-
Corticoliberin, somatocrinin and amine contents in normal and parkinsonian human hypothalamus.Neurosci Lett. 1985 May 14;56(2):217-22. doi: 10.1016/0304-3940(85)90132-6. Neurosci Lett. 1985. PMID: 2409485
-
Amine accumulation in Parkinson's disease and other disorders.Neurosci Biobehav Rev. 1987 Spring;11(1):97-105. doi: 10.1016/s0149-7634(87)80004-0. Neurosci Biobehav Rev. 1987. PMID: 2952907 Review.
Cited by
-
Zebrafish tyrosine hydroxylase 2 gene encodes tryptophan hydroxylase.J Biol Chem. 2013 Aug 2;288(31):22451-9. doi: 10.1074/jbc.M113.485227. Epub 2013 Jun 10. J Biol Chem. 2013. PMID: 23754283 Free PMC article.
-
The significance of selegiline/(-)-deprenyl after 50 years in research and therapy (1965-2015).Mol Psychiatry. 2016 Nov;21(11):1499-1503. doi: 10.1038/mp.2016.127. Epub 2016 Aug 2. Mol Psychiatry. 2016. PMID: 27480491 Review.
-
Human Induced Pluripotent Stem Cell Phenotyping and Preclinical Modeling of Familial Parkinson's Disease.Genes (Basel). 2022 Oct 25;13(11):1937. doi: 10.3390/genes13111937. Genes (Basel). 2022. PMID: 36360174 Free PMC article. Review.
-
Post-mortem distribution of dopamine and homovanillic acid in human brain, variations related to age, and a review of the literature.J Neural Transm. 1979;45(2):81-105. doi: 10.1007/BF01250085. J Neural Transm. 1979. PMID: 381583 Review.
-
Substantia nigra hyperechogenicity is a risk marker of Parkinson's disease: yes.J Neural Transm (Vienna). 2011 Apr;118(4):613-9. doi: 10.1007/s00702-010-0565-6. Epub 2011 Jan 5. J Neural Transm (Vienna). 2011. PMID: 21207077 Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources